Faculty & Staff Details
|Name:||Sara Brouse, Pharm.D., BCPS, AQ-C|
|Position:||Associate Professor, Vice Chair of Residencies, Adult Medicine Division, Dallas VA|
|Bio||Dr. Brouse is one of the founding faculty members of the Texas Tech University HSC School of Pharmacy Dallas Campus. She precepts the cardiology & critical care clerkships for pharmacy students and residents at the North Texas Veterans Administration Medical Center and teaches within the nutrition, drug review, case studies, and grand rounds courses at the school. Dr. Brouse is also the program director for the critical care specialty residency affiliated with both institutions. She received her Pharm.D. degree from the University of Missouri-Kansas City and completed a pharmacy practice & critical care specialty residency at the University of Kentucky Medical Center. Dr. Brouse became a Board Certified Pharmacotherapy Specialist in 2000.|
University of Missouri-Kansas City, Pharm.D., 1997, University of Kentucky Medical Center, Pharmacy Practice Residency, 1997-98, University of Kentucky Medical Center, Critical Care Specialty Residency, 1998-99
Board Certified Pharmacotherapy Specialist, #200120
BCPS Added Qualifications in Cardiology, 4/05
Advanced Cardiac Life Support, 6/10
Basic Cardiac Life Support, 6/10
May 2009 – P2 Teaching Team of the Year, Cardiovascular Pharmacotherapy
June 2002 - P4 Preceptor of the Year, TTUHSC School of Pharmacy 2001-02
May 1997 - Mylan Pharmaceuticals “Excellence In Pharmacy” Award
1995-96 - Pharmacy School Leadership Recognition Award
UMKC School of Pharmacy 1992-93; 1994-95
1996 - Rho Chi Pharmaceutical Honor Society
1991-94 - University of Missouri Curator’s Scholarship
Research Interests: Dr. Brouse’s research interests include drug therapy utilization in decompensated congestive heart failure, and optimal use of sedation and analgesia in critically ill patients.
Practice Focus: Dr. Brouse’s clinical practice is based at the North Texas Veterans Administration (VA) Medical Center in Dallas, TX. She is a clinical pharmacy specialist for both the Medicine ICU and Cardiology ICU teams. The intensive care units are central referral centers for other VA and community medical centers in the North Texas region. The North Texas VA is a major teaching and research site affiliated with the UT Southwestern Medical School.
Professional Service: Dr. Brouse is very active within the American College of Clinical Pharmacy (ACCP). She has been invited several times to give talks on both critical care and cardiology-related subjects at national meetings, including the Board Certification in Pharmacotherapy Specialty Preparatory Course. She is also past-President of the local DFW chapter of ACCP.
Arnold A, Brouse SD, Pitcher WD, Hall RG. Empiric Therapy for Gram-Negative Pathogens in Nosocomial and Health-Care Associated Pneumonia: Starting with the End in Mind. Accepted for publication in Journal of Intensive Care Medicine, 2010; in press.
Hazlewood KL, Brouse SD, Hall RG. Vancomycin-Associated Nephrotoxicity: Grave Concern or Death by Character Assassination? Accepted for publication online in American Journal of Medicine, February 2010; in press.
Brouse SD, Johnson ML, Muldrew KM. Iodine-containing compounds: use in patients with documented adverse reactions. In: Preedy VR, Burrow GN, Watson RR, eds. Comprehensive Handbook on Iodine: Nutritional, Endocrine, and Pathological Aspects. Oxford: Academic Press, 2009, pp 919-925. Elsevier Inc.;2009. ISBN: 978-0-12-374135-6.
Brouse SD. Acute Care Cardiology. The Pharmacotherapy Preparatory Course. 2007 edition. Lenexa, KS: American College of Clinical Pharmacy; 2007:1-38.
Dobesh PP, Brouse SD, Dager WE, Spinler SA, Stacy Z, Wiggins BS. Key articles and guidelines in the management of acute coronary syndromes and in percutaneous coronary intervention: 2007 update. Pharmacotherapy 2007;27(12):1722-58.
Mullin MA, Brouse SD. A comparison of event rates for patients receiving drug-eluting stents versus bare metal stents. J Pharm Technol 2007;23:3-8.
Brouse SD. Agitation/Withdrawal Syndromes. Pharmacotherapy Self-Assessment Program V: Critical Care/Transplantation Book 11. 5th edition. Lenexa, KS: American College of Clinical Pharmacy; 2006: 51-83.
Brouse SD. Pharmacy practice update in the US. J Osaka Pharm Assoc 2006;57(2):20-23.
Dobard M, Brouse SD, Shah MJ. Attainment of cholesterol guidelines in patients at high risk of coronary heart disease [letter]. Am J Health-Syst Pharm 2006;63:212-14.
Brouse SD, Hafezi S. Impact of ß-blocker dosage changes during heart failure exacerbation. J Pharm Technol 2006;22:79-85.
Brouse SD, Umezawa C, Kawasaki K. Evolution of a clinical pharmacy degree program: a US perspective. Jpn J Pharm Health Care Sci 2005; 31(12):969-977.
Akaho E, Brouse SD, Kambara H, Kawasaki K. Enhancing the pharmacist’s professional status through collaborative prescribing: US and Japanese perspectives. Jpn J Pharm Health Care Sci 2005; 31(11):869-882.
Brouse SD, Phillips SM. Amiodarone in Patients with Documented Allergy to Iodine-Containing Compounds. Pharmacotherapy 2005;25(3).
Brouse SD, Wiesehan VG. Evaluation of Bleeding Complications Associated with Glycoprotein IIb/IIIa Inhibitors. Ann Pharmacother 2004;38(11):1783-8.
Dobesh PP, Brouse SD, Johnson DC, Dager WE, Bell D, Daly DE, Olin JL, Wodlinger AM. Key articles and guidelines relative to the management of patients with acute coronary syndromes. Pharmacotherapy 2004;24(1):105-144.
Busti AJ, Vervan MD, Brouse SD. Prednisone for chronic obstructive pulmonary disease [Letter]. New Engl J Med 2003; 349(13):1288-89.
Brouse SD. Medical advisory panel drug class review: Glycoprotein IIb/IIIa receptor inhibitors for use in acute coronary syndromes & percutaneous coronary intervention. Evidence based drug class review for VA national formulary evaluation of GP IIb/IIIa inhibitors. Published on VA PBM website: www.vapbm.org/reviews/glycoproteinreview.pdf. August 2001. Invited.
Brouse SD, Yeager BF, Gelhot AR. Assessment of the treatment of hypertension in a university HMO ambulatory clinic. Journal of Clinical Outcomes Management. 1999;6(9):25-30.
Brouse SD, Vu KL, Hall RG, Pitcher WD. Time to Resolution of Ventilator-Associated Pneumonia. Crit Care Med 2004;32(12):A112. Poster presentation at the 34th Critical Care Congress of SCCM, Phoenix, AZ, January 17, 2005. Contributed.
Cox CD, Stanford BL, Brouse SD, Seifert CF, Haase KK, Akins RL, Bowie VL, Tsikouris JP, Busti A, Shah S, Hall R. Validation of an experiential teaching peer assessment tool. Pharmacotherapy 2004;24:1430 (abstr 62). Poster presentation presented at the ACCP Annual Meeting, Dallas, TX, October 2004. Contributed.
Huang L, Brouse SD. Comparison of patients’ self-reported compliance to medication refill history. Poster Presentation at the Merck/University of Colorado Pharmacy Student Research Conference-Western Region, Denver, CO, June 5, 2004. Contributed.
Brouse SD, Wiesehan VG. Evaluation of bleeding complications following glycoprotein IIb/IIIa inhibitor administration. Poster presentation at the 2nd ACCP-ESCP Joint Meeting, Paris, France, April 29. 2004. Contributed.
Brouse SD, Vu KL. Clinical outcomes following fluid restriction in heart failure exacerbation. Poster Presentation at the 2nd ACCP-ESCP Joint Meeting, Paris, France, April 29, 2004.
Huang L, Brouse SD. Comparison of patients’ self-reported compliance to medication refill history. Poster Presentation at the 38th Annual ASHP Midyear Clinical Meeting, New Orleans, LA, December 9, 2003. Contributed.
Cox CD, Stanford BL, Brouse SD, Seifert CF, Haase KK, Akins RL, Bowie VL, Tsikouris JP, Busti A, Shah S, Hall R. Development and Implementation of an Assessment Tool to Evaluate Experiential Teaching. Pharmacotherapy 2003;23:1336. Poster presentation at the ACCP Annual Meeting, Atlanta, GA, October 2003. Contributed.
Wilson KA, Brouse, SD. Evaluating the association between congestive heart failure and depression. Platform presentation at the Pharmacy Student Research Conference –Western Region, Denver, CO, May 31, 2003. Contributed.
Greene JL, Brouse SD. Impact of a goal-directed sedation strategy in the MICU. Crit Care Med 2002;30(12):A142. Poster Presentation at the 32nd Critical Care Congress of SCCM, San Antonio, TX, February 1, 2003. Contributed.
Hafezi S, Brouse SD. Evaluation of beta-blocker prescribing patterns upon admission for decompensated heart failure. Poster Presentation at the 37th Annual ASHP Midyear Clinical Meeting, Atlanta, GA, December 10, 2002. Contributed.
Holland ME, Brouse SD. Assessing the use of heparin for the prevention of venous thromboembolism. Poster Presentation at the 36th Annual ASHP Midyear Clinical Meeting, New Orleans, LA, December 5, 2001. Contributed.
Threadgill MK, Roberts KW, Brouse SD. Retrospective evaluation of midazolam and lorazepam use in ventilated patients in the medical intensive care unit. Poster Presentation at the 36th Annual ASHP Midyear Clinical Meeting, New Orleans, LA, December 4, 2001. Contributed.
Wiesehan VM, Brouse SD. Retrospective comparison of three glycoprotein 2b/3a inhibitors in the treatment of acute coronary syndromes. Research-in-progress Poster Presentation at the 36th Annual ASHP Midyear Clinical Meeting, New Orleans, LA, December 4, 2001. Contributed.
Brouse SD, Akers WC. Severe isolated thrombocytopenia following antiplatelet administration during acute myocardial infarction. Poster Presentation at the 35th Annual ASHP Midyear Clinical Meeting, Las Vegas, NV, December 4, 2000. Contributed.
Brouse SD, Meyer C, Bryant P. Comparison of MEDLINE access between CD-ROM and internet vendors. Poster Presentation at the 33rd Annual ASHP Midyear Clinical Meeting, Las Vegas, NV, December 9, 1998. Contributed.
Brouse SD, Yeager BF, Gelhot AR. Assessment of the treatment of hypertension in a university HMO ambulatory clinic. Poster Presentation at the ACCP Spring Practice and Research Forum, Palm Springs, CA, April 7, 1998. Contributed.